The Globe and Mail spoke with eight people whose pet’s health declined after taking Librela. Drugmaker Zoetis has responded ...
WINNIPEG, Manitoba, Nov. 14, 2024 (GLOBE NEWSWIRE) -- Kane Biotech Inc. (TSX- V:KNE; OTCQB:KNBIF) (the “Company” or “Kane Biotech”) announces today that it has received Health Canada approval of its ...
From an estimated $150 billion of spending in 2024, the category is expected to mushroom up to roughly $200 billion by 2030, ...
announced today that Health Canada has approved JORNAY PM™, an extended-release formulation of methylphenidate, a stimulant medication for the treatment of Attention-Deficit Hyperactivity Disorder ...